1
|
Cordeiro MF, Nunes TRS, Bezerra FG, Damasco PKM, Silva WAV, Ferreira MRA, Magalhães OMC, Soares LAL, Cavalcanti IMF, Pitta MGR, Rêgo MJBM. Phytochemical characterization and biological activities of Plectranthus barbatus Andrews. BRAZ J BIOL 2021; 82:e236297. [PMID: 33787716 DOI: 10.1590/1519-6984.236297] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 07/09/2020] [Indexed: 11/22/2022] Open
Abstract
Plectranthus barbatus Andrews (Lamiaceae) is widely distributed in the world and has a range of popular therapeutic indications. This work aimed to evaluate the phytochemical characterization of two leaf extracts of P. barbatus, and their antimicrobial, antineoplastic and immunomodulatory potential. After collection, herborization and obtainment of the P. barbatus aqueous extract (PBA) and acetone:water 7:3 P. barbatus organic extract (PBO), the phytochemical characterization was performed by high-performance liquid chromatography (HPLC). The antimicrobial activity was performed to determine the minimum inhibitory concentration (MIC) against eight bacterial strains using the microdilution test and the fungus Trichophyton rubrum by disc diffusion assay and microdilution test. Cytotoxicity was assessed by MTT and trypan blue methods in normal peripheral blood mononuclear cells (PBMCs) at concentrations ranged between 0.1 to 100 µg.mL-1 and in neoplastic cell lines Toledo, K562, DU-145 and PANC-1 at 1, 10 and 100 µg.mL-1 . Immunomodulatory activity, was evaluated by sandwich ELISA of proinflammatory cytokines at BALB/c mice splenocytes cultures supernatant. Both extracts presented flavonoids, cinnamic derivatives, steroids and ellagic acid. PBO showed bacteriostatic activity against Acinetobacter baumannii (MIC = 250 µg.mL-1) clinical isolate and PBA fungistatic activity against Trichophyton rubrum (MIC = 800 µg.mL-1). The extracts did not exhibit toxicity to PBMCs and neoplastic cells (IC50 > 100 µg.mL-1). Additionally, PBO at 100 µg.mL-1 significantly inhibited IFN-γ and IL-17A cytokines (p = 0.03). Plectranthus barbatus is a potential candidate for therapeutic use due to its low toxicity in healthy human cells and exhibits biological activities of medical interest as bacteriostatic, fungistatic and immunomodulatory.
Collapse
Affiliation(s)
- M F Cordeiro
- Universidade Federal de Pernambuco - UFPE, Research Centre for Therapeutic Innovation - Suely Galdino - NUPIT-SG, Laboratory of Immunomodulation and New Therapeutical Approaches, Recife, PE, Brasil.,Universidade Federal do Vale do São Francisco - UNIVASF, Medicine Collegiate, Paulo Afonso, BA, Brasil
| | - T R S Nunes
- Universidade Federal de Pernambuco - UFPE, Research Centre for Therapeutic Innovation - Suely Galdino - NUPIT-SG, Laboratory of Immunomodulation and New Therapeutical Approaches, Recife, PE, Brasil
| | - F G Bezerra
- Universidade Federal de Pernambuco - UFPE, Research Centre for Therapeutic Innovation - Suely Galdino - NUPIT-SG, Laboratory of Immunomodulation and New Therapeutical Approaches, Recife, PE, Brasil
| | - P K M Damasco
- Universidade Federal de Pernambuco - UFPE, Micology Department, Recife, PE, Brasil
| | - W A V Silva
- Universidade Federal de Pernambuco - UFPE, Pharmacy Department, Recife, PE, Brasil
| | - M R A Ferreira
- Universidade Federal de Pernambuco - UFPE, Pharmacy Department, Recife, PE, Brasil
| | - O M C Magalhães
- Universidade Federal de Pernambuco - UFPE, Micology Department, Recife, PE, Brasil
| | - L A L Soares
- Universidade Federal de Pernambuco - UFPE, Pharmacy Department, Recife, PE, Brasil
| | - I M F Cavalcanti
- Universidade Federal de Pernambuco - UFPE, Laboratory of Immunopathology Keizo Asami, Recife, PE, Brasil
| | - M G R Pitta
- Universidade Federal de Pernambuco - UFPE, Research Centre for Therapeutic Innovation - Suely Galdino - NUPIT-SG, Laboratory of Immunomodulation and New Therapeutical Approaches, Recife, PE, Brasil
| | - M J B M Rêgo
- Universidade Federal de Pernambuco - UFPE, Research Centre for Therapeutic Innovation - Suely Galdino - NUPIT-SG, Laboratory of Immunomodulation and New Therapeutical Approaches, Recife, PE, Brasil
| |
Collapse
|
2
|
Dantas LLSFR, Fonseca AG, Pereira JR, Furtado AA, Gomes PATM, Fernandes-Pedrosa MF, Leite ACL, Rêgo MJBM, Pitta MGR, Lemos TMAM. Anti-inflammatory and antinociceptive effects of the isatin derivative (Z)-2-(5-chloro-2-oxoindolin-3-ylidene)-N-phenyl-hydrazinecarbothioamide in mice. ACTA ACUST UNITED AC 2020; 53:e10204. [PMID: 32901685 PMCID: PMC7485313 DOI: 10.1590/1414-431x202010204] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2020] [Accepted: 06/22/2020] [Indexed: 11/22/2022]
Abstract
Several isatin derivatives have shown important biological activities, which have attracted interest from researchers. For this reason, the present study aimed to evaluate the anti-inflammatory and antinociceptive effects of the isatin derivative (Z)-2-(5-chloro-2-oxoindolin-3-ylidene)-N-phenyl-hydrazinecarbothioamide (COPHCT) in mice. Three doses of this compound were tested: 1.0, 2.5, and 5.0 mg/kg. The anti-inflammatory activity was assessed using the carrageenan-induced paw edema model and the zymosan-induced air pouch model. The evaluation of the antinociceptive effect was performed through the formalin test and the acetic acid-induced abdominal writhing test. The paw edema assay demonstrated that all doses of the compound showed a significant reduction of the edema in the second hour evaluated, but a better response was observed in the fourth hour. The zymosan-induced air pouch model indicated that the compound, in all doses, significantly reduced leukocyte migration and total protein concentration levels. In the formalin test, the doses 1.0, 2.5, and 5.0 mg/kg of COPHCT showed activity only in the second phase, with reduction in paw pain time of 73.61, 79.46, and 73.85%, respectively. The number of abdominal writhings decreased with the increasing dose, but only 5.0 mg/kg COPHCT exhibited a significant response, with a reduction of 24.88%. These results demonstrated the ability of this compound to interfere in the anti-inflammatory activity of edema, vascular permeability, and cell migration. In addition, its possible antinociceptive effect may be related to the dose used.
Collapse
Affiliation(s)
- L L S F R Dantas
- Programa de Pós-Graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
| | - A G Fonseca
- Programa de Pós-Graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
| | - J R Pereira
- Programa de Pós-Graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
| | - A A Furtado
- Programa de Pós-Graduação em Bioquímica, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
| | - P A T M Gomes
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - M F Fernandes-Pedrosa
- Programa de Pós-Graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil.,Programa de Pós-Graduação em Bioquímica, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil.,Departamento de Farmácia, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
| | - A C L Leite
- Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife, PE, Brasil.,Departamento de Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - M J B M Rêgo
- Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - M G R Pitta
- Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - T M A M Lemos
- Programa de Pós-Graduação em Desenvolvimento e Inovação Tecnológica em Medicamentos, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil.,Departamento de Análises Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal, RN, Brasil
| |
Collapse
|
3
|
Matos-Rocha TJ, Lima MCAD, Veras DL, Santos AF, Silva AL, Almeida Júnior ASA, Pitta-Galdino MR, Pitta IR, Pitta MGR, Alves LC, Brayner FA. In vivo study of schistosomicidal action of (Z)-1-(2-chloro-6-fluoro-benzyl)-5-thioxo-4-(2,4,6-trimethoxy-benzylidene)-imidazolidin-2-one. BRAZ J BIOL 2019; 80:187-189. [PMID: 31166369 DOI: 10.1590/1519-6984.190062] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 10/28/2018] [Indexed: 11/21/2022] Open
Affiliation(s)
- T J Matos-Rocha
- Laboratório de Biologia Celular e Molecular, Departamento de Parasitologia, Centro de Pesquisas Aggeu Magalhães, Recife, PE, Brasil.,Laboratório de Imunopatologia Keizo Asami, Universidade Federal de Pernambuco - UFPE, Recife, Pernambuco, Brasil
| | - M C Alves de Lima
- Laboratório de Planejamento e Síntese de Fármacos, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - D L Veras
- Laboratório de Biologia Celular e Molecular, Departamento de Parasitologia, Centro de Pesquisas Aggeu Magalhães, Recife, PE, Brasil
| | - A F Santos
- Laboratório de Biologia Celular e Molecular, Departamento de Parasitologia, Centro de Pesquisas Aggeu Magalhães, Recife, PE, Brasil
| | - A L Silva
- Laboratório de Planejamento e Síntese de Fármacos, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - A S A Almeida Júnior
- Laboratório de Planejamento e Síntese de Fármacos, Universidade Federal de Pernambuco, Recife, PE, Brasil
| | - M R Pitta-Galdino
- Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino, Recife, PE, Brasil
| | - I R Pitta
- Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino, Recife, PE, Brasil
| | - M G R Pitta
- Laboratório de Imunomodulação e Novas Abordagens Terapêuticas, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino, Recife, PE, Brasil
| | - L C Alves
- Laboratório de Biologia Celular e Molecular, Departamento de Parasitologia, Centro de Pesquisas Aggeu Magalhães, Recife, PE, Brasil
| | - F A Brayner
- Laboratório de Biologia Celular e Molecular, Departamento de Parasitologia, Centro de Pesquisas Aggeu Magalhães, Recife, PE, Brasil
| |
Collapse
|
4
|
Chagas MBO, Cordeiro NCC, Marques KMR, Rocha Pitta MG, Rêgo MJBM, Lima MCA, Pitta MGR, Pitta IR. New thiazacridine agents: Synthesis, physical and chemical characterization, and in vitro anticancer evaluation. Hum Exp Toxicol 2016; 36:1059-1070. [DOI: 10.1177/0960327116680274] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
A series of new thiazacridine agents were synthesized and evaluated as antitumor agents, in terms of not only their cytotoxicity but also their selectivity. The cytotoxicity assay confirmed that all compounds showed cytotoxic activity and selectivity. The new compound, 3-acridin-9-ylmethyl-5-(5-bromo-1 H-indol-3-ylmethylene)-thiazolidine-2,4-dione (LPSF/AA29 – 7a), proved to be the most promising compound as it presents lower half-maximal inhibitory concentration (IC50) values (ranging from 0.25 to 68.03 µM) depending on cell lineage. In HepG2 cells, the lowest IC50 value was exhibited by 3-acridin-9-ylmethyl-5-(4-piperidin-1-yl-benzylidene)-thiazolidine-2,4-dione (LPSF/AA36 – 7b; 46.95 µM). None of the synthesized compounds showed cytotoxic activity against normal cells (IC50 > 100 µM). The mechanism of death induction and cell cycle effects was also evaluated. Flow cytometric analysis revealed that the compounds LPSF/AA29 – 7a and LPSF/AA36 – 7b significantly increased the percentage of apoptotic cells and induced G2/M arrest in the cell cycle progression. Therefore, these new thiazacridine derivatives constitute promising antitumor agents whose cytotoxicity and selectivity properties indicate they have potential to contribute to or serve as a basis for the development of new cancer drugs in the future.
Collapse
Affiliation(s)
- MBO Chagas
- Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - NCC Cordeiro
- Laboratory for Planning and Drug Synthesis, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - KMR Marques
- Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - MG Rocha Pitta
- Laboratory for Planning and Drug Synthesis, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - MJBM Rêgo
- Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - MCA Lima
- Laboratory for Planning and Drug Synthesis, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - MGR Pitta
- Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| | - IR Pitta
- Laboratory for Immunomodulation and New Therapeutic Approaches, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
- Laboratory for Planning and Drug Synthesis, Federal University of Pernambuco (UFPE), Recife, PE, Brazil
| |
Collapse
|
5
|
Albuquerque MCPA, Silva TG, Pitta MGR, Silva ACA, Silva PG, Malagueño E, Santana JV, Wanderley AG, Lima MCA, Galdino SL, Barbe J, Pitta IR. Synthesis and schistosomicidal activity of new substituted thioxo-imidazolidine compounds. Pharmazie 2005; 60:13-7. [PMID: 15700773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
Synthesis and physico-chemical properties of 3-benzyl-5-(4-fluoro-benzylidene)-1-methyl-2-thioxo-imidazolidin-4-ones, 5-benzylidene-3-(4-nitro-benzyl)-2-thioxo-imidazolidin-4-ones and 4-acridin-9-ylmethylene-1-benzyl-5-thioxo-imidazolidin-2-ones compounds are described. These thioxo-imidazolidine derivatives were prepared by alkylation and condensation with 4-fluoro-benzaldehyde or nucleophilic Michael addition with cyanoacrylates. The schistosomicidal activity of 3-benzyl-5-(4-fluoro-benzylidene)-1-methyl-2-thioxo-imidazolidin-4-one compounds was evaluated.
Collapse
Affiliation(s)
- M C P A Albuquerque
- Laboratorio de Imunopatologia Keizo Asami - LIKA, Centro de Ciências Biológicas, Universidade Federal de Pernambuco - UFPE, Recife, Brasil
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|